BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27864344)

  • 21. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
    Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
    Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice.
    Jung M; Ryu YJ; Kang G
    Pathol Res Pract; 2015 Dec; 211(12):925-30. PubMed ID: 26564105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
    Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
    J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
    Kang MR; Yang G; Place RF; Charisse K; Epstein-Barash H; Manoharan M; Li LC
    Cancer Res; 2012 Oct; 72(19):5069-79. PubMed ID: 22869584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
    Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
    Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment.
    Sun X; Ackerstaff E; He F; Xing L; Hsiao HT; Koutcher JA; Ling CC; Li GC
    Oncotarget; 2015 Oct; 6(33):34732-44. PubMed ID: 26416246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.
    Plante MK; Arscott WT; Folsom JB; Tighe SW; Dempsey RJ; Wesley UV
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):16-22. PubMed ID: 22986577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
    Zhang B; Jiang T; Ling L; Cao Z; Zhao J; Tuo Y; She X; Shen S; Jiang X; Hu Y; Pang Z
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8918-27. PubMed ID: 26890991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
    Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies of targeting pathological stroma for enhanced antitumor therapies.
    Zhu Y; Yu F; Tan Y; Yuan H; Hu F
    Pharmacol Res; 2019 Oct; 148():104401. PubMed ID: 31422113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
    Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
    Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin suppresses gastric cancer progression through calmodulin‑like protein 3 secreted from tumor‑associated fibroblasts.
    Chen G; Yu C; Tang Z; Liu S; An F; Zhu J; Wu Q; Cao J; Zhan Q; Zhang S
    Oncol Rep; 2019 Jan; 41(1):405-414. PubMed ID: 30320344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
    Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.
    Tian X; Nguyen M; Foote HP; Caster JM; Roche KC; Peters CG; Wu P; Jayaraman L; Garmey EG; Tepper JE; Eliasof S; Wang AZ
    Cancer Res; 2017 Jan; 77(1):112-122. PubMed ID: 27784746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.